SCHEMBL10072108

SCHEMBL10072108

O=C(CO)COCCc1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 3/20 0.47
▸ HCAR2 Q8TDS4 1/20 0.45
▸ KEAP1 Q14145 1/20 0.44
▸ FFAR1 O14842 2/20 0.44
▸ ESR1 P03372 1/20 0.44
▸ ESR2 Q92731 1/20 0.44
▸ LMNA P02545 1/20 0.43
▸ NPC1 O15118 2/20 0.42
▸ RAB9A P51151 2/20 0.42
▸ L3MBTL1 Q9Y468 2/20 0.42
▸ ALDH1A1 P00352 2/20 0.42
▸ MAPK1 P28482 2/20 0.42
▸ SMN1; SMN2 Q16637 2/20 0.42
▸ TP53 P04637 1/20 0.42
▸ GLA P06280 1/20 0.42
▸ CYP3A4 P08684 1/20 0.42
▸ HPGD P15428 1/20 0.42
▸ TSHR P16473 1/20 0.42
▸ HIF1A Q16665 1/20 0.42
▸ HSD17B10 Q99714 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30984457 0.84 TDP1 (0.46) TDP1HCAR2KEAP1FFAR1ESR1
SCHEMBL30984441 0.84 TDP1 (0.46) TDP1HCAR2KEAP1FFAR1ESR1
SCHEMBL30984460 0.84 TDP1 (0.46) TDP1HCAR2KEAP1FFAR1ESR1
SCHEMBL3248092 0.82 FFAR4 (0.55) TDP1HCAR2KEAP1FFAR1ESR1
SCHEMBL9956104 0.81 TSHR (0.54) TDP1NPC1RAB9AL3MBTL1ALDH1A1
SCHEMBL3884363 0.81 FFAR4 (0.54) TDP1HCAR2KEAP1FFAR1ESR1
Hydrochloric Acid SCHEMBL7690739 0.81 FFAR4 (0.54) TDP1HCAR2KEAP1FFAR1ESR1
SCHEMBL8531827 0.79 FFAR4 (0.52) TDP1HCAR2KEAP1FFAR1ESR1
SCHEMBL3257614 0.79 TDP1 (0.48) TDP1HCAR2KEAP1FFAR1ESR1
SCHEMBL3884361 0.79 FFAR4 (0.52) TDP1HCAR2KEAP1FFAR1ESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130272978-A1 DIHYDROXYACETONE MONOETHERS MERCK PATENT GMBH (DE) 2013-10-17 — — US disclosed
US-20130272978-A1 DIHYDROXYACETONE MONOETHERS MERCK PATENT GMBH (DE) 2013-10-17 — — US disclosed
WO-2012084121-A1 DIHYDROXYACETONE MONOETHER MERCK PATENT GMBH (DE) 2012-06-28 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130272978-A1 DIHYDROXYACETONE MONOETHERS GNPAT, UGT1A7, UGT1A3 TDP1 1476/4885HCAR2 1917/4885KEAP1 168/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback